H.C. Wainwright reiterates IN8bio stock rating, $6 target on trial data

H.C. Wainwright reiterates IN8bio stock rating, $6 target on trial data

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.